v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance at beginning of the period (in shares) at Dec. 31, 2024       188,626,154 26,426,937    
Balance at beginning of the period at Dec. 31, 2024 $ 168,832     $ 19 $ 3 $ 970,940 $ (802,130)
Increase (Decrease) in Stockholders' Equity              
Net loss (27,801)           (27,801)
Net proceeds from share offering (in shares)       27,600,000      
Net proceeds from share offering 81,006     $ 3   81,003  
Common stock issued upon exercise of stock options (in shares)       179,503      
Common stock issued upon exercise of stock options 274         274  
Common stock issued upon vesting of restricted stock units, net (in shares)       7,077,422      
Common stock issued upon vesting of restricted stock units, net (2,775)         (2,775)  
Common stock issued for employee stock purchase plan (in shares)       1,126,754      
Common stock issued for employee stock purchase plan 949         949  
Stock-based compensation expense 12,321         12,321  
Balance at end of the period (in shares) at Jun. 30, 2025       224,609,833 26,426,937    
Balance at end of the period at Jun. 30, 2025 232,806     $ 22 $ 3 1,062,712 (829,931)
Balance at beginning of the period (in shares) at Mar. 31, 2025       220,818,648 26,426,937    
Balance at beginning of the period at Mar. 31, 2025 239,696     $ 22 $ 3 1,055,768 (816,097)
Increase (Decrease) in Stockholders' Equity              
Net loss (13,834)           (13,834)
Net proceeds from share offering (104)         (104)  
Common stock issued upon exercise of stock options (in shares)       99,676      
Common stock issued upon exercise of stock options 142         142  
Common stock issued upon vesting of restricted stock units, net (in shares)       2,564,755      
Common stock issued for employee stock purchase plan (in shares)       1,126,754      
Common stock issued for employee stock purchase plan 949         949  
Stock-based compensation expense 5,957         5,957  
Balance at end of the period (in shares) at Jun. 30, 2025       224,609,833 26,426,937    
Balance at end of the period at Jun. 30, 2025 232,806     $ 22 $ 3 1,062,712 (829,931)
Balance at beginning of the period (in shares) at Dec. 31, 2025   227,318,426 26,426,937 227,318,426 26,426,937    
Balance at beginning of the period at Dec. 31, 2025 195,979     $ 23 $ 3 1,075,147 (879,194)
Increase (Decrease) in Stockholders' Equity              
Net loss $ (25,587)           (25,587)
Common stock issued upon exercise of stock options (in shares) 1,662,938     1,662,938      
Common stock issued upon exercise of stock options $ 5,031         5,031  
Common stock issued upon vesting of restricted stock units, net (in shares)       7,703,171      
Common stock issued upon vesting of restricted stock units, net (6)     $ 1   (7)  
Common stock issued for employee stock purchase plan (in shares)       1,310,944      
Common stock issued for employee stock purchase plan 1,233         1,233  
Stock-based compensation expense 12,750         12,750  
Balance at end of the period (in shares) at Jun. 30, 2026   237,995,479 26,426,937 237,995,479 26,426,937    
Balance at end of the period at Jun. 30, 2026 189,400     $ 24 $ 3 1,094,154 (904,781)
Balance at beginning of the period (in shares) at Mar. 31, 2026       234,777,441 26,426,937    
Balance at beginning of the period at Mar. 31, 2026 191,222     $ 23 $ 3 1,083,067 (891,871)
Increase (Decrease) in Stockholders' Equity              
Net loss (12,910)           (12,910)
Common stock issued upon exercise of stock options (in shares)       752,277      
Common stock issued upon exercise of stock options 2,722         2,722  
Common stock issued upon vesting of restricted stock units, net (in shares)       1,154,817      
Common stock issued upon vesting of restricted stock units, net (6)     $ 1   (7)  
Common stock issued for employee stock purchase plan (in shares)       1,310,944      
Common stock issued for employee stock purchase plan 1,233         1,233  
Stock-based compensation expense 7,139         7,139  
Balance at end of the period (in shares) at Jun. 30, 2026   237,995,479 26,426,937 237,995,479 26,426,937    
Balance at end of the period at Jun. 30, 2026 $ 189,400     $ 24 $ 3 $ 1,094,154 $ (904,781)